Target intelligence / Profile preview

Ribosomal protein L36a pseudogene 5 (RPL36AP5)

Target
RPL36AP5
Molecular classification
Other, Pseudogene
01

Overview

Ribosomal protein L36a pseudogene 5 (RPL36AP5) is a processed pseudogene in the human genome. It does not encode a functional protein and instead represents a genomic remnant derived from the ribosomal protein L36a gene family, which is involved in protein synthesis as part of the large 60S ribosomal subunit. RPL36AP5 is non-coding and not associated with any known biological function, disease process, or therapeutic targeting[8][2].

Other names
RPL36A_9_691bA256G5.1

Beyond the preview

Go deeper on Ribosomal protein L36a pseudogene 5 (RPL36AP5).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L36a pseudogene 5 (RPL36AP5).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call